Study reveals racial disparities in Lyme disease diagnosis and treatment, with Black patients experiencing longer delays and higher risks of disseminated disease compared to White patients.
Mirum’s plans to expand Livmarli’s market get hit as FDA pushes approval date – Pharmaceutical Technology
Livmarli is approved by the FDA for the treatment of cholestatic pruritus in patients with Alagille Syndrome. Credit: bankrx via Getty Images. The US Food
October 18, 2023